Product Launch

One Times Square now offers limited-time tickets for an up-close look at the famous New Year's Eve Ball before the building's grand 2026 reopening.

A new AI accelerator promises to cut the complex Adobe Experience Platform migration from weeks to days, reshaping digital transformation timelines.

A look inside the revolutionary mass timber, net-zero building that's setting a new global standard for sustainable construction and education.

A new standing wheelchair module offers unprecedented height, blending advanced engineering with profound health and social benefits for users.

A new tech platform is giving homeowners a verified voice, using a "Trust Index" to rate HOAs and disrupt the $11 trillion community housing market.

Interactive Brokers' redesigned GlobalTrader app blends AI-powered insights and a user-friendly interface to make global markets more accessible than ever.

Millions struggle to swallow pills. Azurity's new FDA-approved liquid hypertension drug, Javadin, offers a ready-to-use solution for better adherence.

The digital signage firm's new virtual environment lets users explore a full installation, from emergency alerts to video walls, on any device.

Kia's new K4 Hatchback aims to disrupt the compact car market with aggressive pricing, a powerful turbo option, and a standard tech suite rivals can't match.

As AI drives innovation, it also fuels a projected $10 trillion in cyber losses. Experts warn reactive security is failing and a proactive shift is vital.

With over 100 million inspections in 2025, AI is making auto service faster, safer, and more transparent, tackling labor shortages along the way.

AODocs’ new SAP S/4HANA certification brings AI-powered document management to the ERP, promising lower costs, better compliance, and smarter workflows.

Experian's new 'BFF' campaign with Fred Warner and Puka Nacua aims to make you the MVP of your finances. But does the star power deliver real value?

A breakthrough genetic test helps prostate cancer patients avoid severe side effects from radiation while saving the healthcare system millions of dollars.

A new FDA approval for an EGFR-mutated lung cancer therapy cuts treatment from hours to minutes, offering new hope and convenience for thousands of patients.

Celltrion's SteQeyma autoinjector gets a CHMP nod, enhancing patient care and intensifying competition in Europe's crowded biosimilar market.

Early Phase 1a data for Kalaris's new nAMD drug shows significant vision improvement and potential for extended durability, aiming to reduce patient burden.

Haier's immersive festival in KL isn't just about new gadgets. It's a strategic play for brand loyalty in Malaysia's booming smart home market.

As the market for oral supplements explodes, products like Synadentix promise a healthier mouth. But does the science back the billion-dollar marketing?

EMASS's new ultra-low-power 16nm SoC integrates advanced AI and BLE, aiming to revolutionize always-on intelligence in wearables, drones, and IoT.